|
Pallister-Hall syndrome
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome.
|
9054938 |
1997 |
|
Pallister-Hall syndrome
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome.
|
9054938 |
1997 |
|
Pallister-Hall syndrome
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
GLI3 mutations have been implicated in the mouse mutant extra toes, as well as in human Greig cephalopolydactaly syndrome and the autosomal dominant form of Pallister-Hall syndrome.
|
9440116 |
1997 |
|
Pallister-Hall syndrome
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
We have previously shown GLI3 mutations in two other small, moderately affected families with Pallister-Hall syndrome.
|
9192261 |
1997 |
|
Pallister-Hall syndrome
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome.
|
9054938 |
1997 |
|
Pallister-Hall syndrome
|
0.900 |
GeneticVariation
|
disease |
CLINVAR |
We studied the involvement of GLI3 in additional phenotypes of digital abnormalities in one family (UR003) with preaxial polydactyly type-IV (PPD-IV), three families (UR014, UR015, and UR016) with dominant PAP-A/B (with PPD-A and -B in the same family), and one family with PHS.
|
10441570 |
1999 |
|
Pallister-Hall syndrome
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
In addition to GCPS, Pallister-Hall syndrome (PHS; MIM 146510) and post-axial polydactyly type A (PAP-A; MIM 174200), two other disorders of human development, are caused by GLI3 mutations.
|
10441342 |
1999 |
|
Pallister-Hall syndrome
|
0.900 |
Biomarker
|
disease |
BEFREE |
We studied the involvement of GLI3 in additional phenotypes of digital abnormalities in one family (UR003) with preaxial polydactyly type-IV (PPD-IV), three families (UR014, UR015, and UR016) with dominant PAP-A/B (with PPD-A and -B in the same family), and one family with PHS.
|
10441570 |
1999 |
|
Pallister-Hall syndrome
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
We studied the involvement of GLI3 in additional phenotypes of digital abnormalities in one family (UR003) with preaxial polydactyly type-IV (PPD-IV), three families (UR014, UR015, and UR016) with dominant PAP-A/B (with PPD-A and -B in the same family), and one family with PHS.
|
10441570 |
1999 |
|
Pallister-Hall syndrome
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
The PAP-A mutant protein (GLI3-PAP-A) showed less specific subcellular localization but still inhibited GLI3-activated PTCH1 transcription, suggesting it may be a weaker allele than the GLI3-PHS mutation.
|
10077605 |
1999 |
|
Pallister-Hall syndrome
|
0.900 |
Biomarker
|
disease |
MGD |
Pallister-Hall syndrome phenotype in mice mutant for Gli3.
|
11978771 |
2002 |
|
Pallister-Hall syndrome
|
0.900 |
GeneticVariation
|
disease |
LHGDN |
Gene symbol: GLI3. Disease: Pallister-Hall syndrome.
|
12575661 |
2003 |
|
Pallister-Hall syndrome
|
0.900 |
CausalMutation
|
disease |
CLINVAR |
To test these hypotheses, we screened patients with PHS and GCPS for GLI3 mutations.
|
15739154 |
2005 |
|
Pallister-Hall syndrome
|
0.900 |
Biomarker
|
disease |
BEFREE |
We hypothesized that GLI3 mutations that predict a truncated functional repressor protein cause PHS and that functional haploinsufficiency of GLI3 causes GCPS.
|
15739154 |
2005 |
|
Pallister-Hall syndrome
|
0.900 |
Biomarker
|
disease |
CTD_human |
To test these hypotheses, we screened patients with PHS and GCPS for GLI3 mutations.
|
15739154 |
2005 |
|
Pallister-Hall syndrome
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
To test these hypotheses, we screened patients with PHS and GCPS for GLI3 mutations.
|
15739154 |
2005 |
|
Pallister-Hall syndrome
|
0.900 |
GeneticVariation
|
disease |
CLINVAR |
To test these hypotheses, we screened patients with PHS and GCPS for GLI3 mutations.
|
15739154 |
2005 |
|
Pallister-Hall syndrome
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
This report further expands the PHS phenotype and raises the possibility of specific GLI3 mutations resulting in more severe skeletal features.
|
16007608 |
2005 |
|
Pallister-Hall syndrome
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Here, we report that cochleae from a mouse model of PHS (Gli3(Delta699)), which produces only the truncated, repressor form of GLI3, have a variably penetrant phenotype that includes an increase in the size of the sensory epithelium and the development of large ectopic sensory patches in Kölliker's organ (KO).
|
18632939 |
2008 |
|
Pallister-Hall syndrome
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Approximately 5% of HH cases are associated with Pallister-Hall syndrome (PHS), which is caused by haploinsufficiency of GLI3.
|
18252217 |
2008 |
|
Pallister-Hall syndrome
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Mutations that lead to loss of function of the protein and to haploinsufficiency cause GCPS, while truncating mutations that result in constitutive repressor function of GLI3 lead to PHS.
|
19829694 |
2009 |
|
Pallister-Hall syndrome
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Most of the time, this hamartoma occurs in Pallister-Hall syndrome (PHS), due to heterozygous GLI3 mutations.
|
19449422 |
2009 |
|
Pallister-Hall syndrome
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
The most important issue might be that GCPS and PHS exhibit an autosomal dominant trait, but mouse homologs, such as Pdn/Pdn, Xt(H)/Xt(H), Xt(J)/Xt(J) and Gli3(tmlUrt)/Gli3(tmlUrt), are autosomal recessive traits in the manifestation of similar phenotypes to human diseases.
|
20201963 |
2010 |
|
Pallister-Hall syndrome
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
The urogenital and anorectal abnormalities associated with PHS might be related to dysregulation of SHH signaling caused by GLI3 mutations rather than hormonal aberrations.
|
21108399 |
2010 |
|
Pallister-Hall syndrome
|
0.900 |
CausalMutation
|
disease |
CLINVAR |
Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations.
|
20672375 |
2010 |